Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01936259 · ClinicalTrials.gov registry record · NA

Comprehensive Shoulder System Nano IDE

A NA study of Joint Disease, sponsored by Zimmer Biomet.

Completed
Registry status
NA
Development phase
258
Enrollment target
12
Study locations

NCT01936259 is a NA study of Joint Disease that has completed, run by Zimmer Biomet. The registered enrollment target is 258 participants, above the 108-participant average among 4 other Joint Disease trials with a reported enrollment target (139% higher). The trial reports 12 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01936259, a NA study of Joint Disease, has completed, sponsored by Zimmer Biomet.

COMPLETED
Registry status
NA
Development phase
258 participants
Enrollment target
12
Study locations

Study Summary

The purpose of this clinical study is to determine the safety and efficacy of the Comprehensive® Shoulder System with Nano Humeral Component in Total Shoulder Arthroplasty (TSA).

Conditions Studied

Interventions

  • DEVICE Mini Stem
  • DEVICE Nano

Study Locations (12)

Virginia

  • University of Virginia - Charlottesville
  • Bon Secours St. Francis Medical Center - Midlothian

Arizona

  • Arizona Institute for Sports, Knees, and Shoulders - Scottsdale

Florida

  • Holy Cross Hospital - Fort Lauderdale

Indiana

  • Ortho NorthEast - Fort Wayne

Louisiana

  • Orthopedic Clinic - Shreveport

Maryland

  • Towson Orthopaedic Associates - Towson

Michigan

  • William Beaumont Hospital - Royal Oak

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 258 participants
Start Date 2013-08
Est. Completion 2019-09-27
Phase NA

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT01936259

The ClinicalTrials.gov registry entry for NCT01936259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 108-participant average among 4 other Joint Disease trials with a reported enrollment target (139% higher). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Joint Disease appearing as the primary indexed condition, and to 2 interventions - of which Mini Stem is the first listed.

NCT01936259 reports 12 study locations spanning 11 distinct geographic areas - top geographies include Virginia, Arizona, Florida.

Frequently Asked Questions

What is clinical trial NCT01936259 about?

NCT01936259 is a clinical study titled "Comprehensive Shoulder System Nano IDE". The purpose of this clinical study is to determine the safety and efficacy of the Comprehensive® Shoulder System with Nano Humeral Component in Total Shoulder Arthroplasty (TSA).

What is the current status of trial NCT01936259?

This trial is currently completed. It is a NA study. The enrollment target is 258 participants. The study started on 2013-08. Estimated completion is 2019-09-27.

What conditions does trial NCT01936259 study?

This clinical trial studies the following conditions: Joint Disease.

What interventions are being tested in trial NCT01936259?

The interventions under investigation include: Mini Stem (DEVICE), Nano (DEVICE).

Who is sponsoring clinical trial NCT01936259?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01936259 being conducted?

This trial has 12 study locations across Arizona, Florida, Indiana, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Joint Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.